Friday, September 27, 2013

A Phase III Failure at Eli Lilly. Yes, Again.

We need an analysis like this for stroke drugs.
From Derek Lowe atIn the Pipeline blog.
There are 1000 stroke failures that Dr. Michael Tymianski has referred to that need this type of analysis. A great stroke association would already have a database of all the failures and use that to create a forward looking plan to get to success. But we have crap for stroke survivor support and prevention of disability.
http://pipeline.corante.com/archives/2013/09/27/a_phase_iii_failure_at_eli_lilly_yes_again.php

No comments:

Post a Comment